# OnCo record conko-001 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/conko-001/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "conko-001", "ISRCTN34802808" ;
  schema:name "CONKO-001"@en ;
  schema:alternateName "CONKO 001"@en, "CONKO-1"@en ;
  schema:description "CONKO-001 was the trial that made chemotherapy after pancreatic cancer surgery routine: six months of gemcitabine doubled the time before the cancer came back and roughly doubled the share of patients alive at five years, from 10 to 21 percent."@en ;
  schema:url <https://onco.cc/trials/conko-001/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://www.isrctn.com/ISRCTN34802808> ;
  onco:status "positive" ;
  onco:tag "soc-trials" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/resectable-pdac/>, <https://onco.cc/cancers/pancreatic/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/gemcitabine/> ;
  onco:institutions <https://onco.cc/institutions/charite/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-conko-001-adjuvant-gemcitabine-long-term-oettle-jama-2013/> .